Satsuma Pharmaceuticals Eulerpool naujienos

Satsuma Pharmaceuticals Eulerpool News

Satsuma Pharmaceuticals akcijų naujienos

Satsuma Pharmaceuticals stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias Satsuma Pharmaceuticals naujienas mes pateikiame čia.

• liepos 17 d. ·

  SeekingAlpha
  Leaven Partners Second Quarter 2023 Letter To Partners
• birželio 9 d. ·

  Benzinga
  Satsuma Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying
• gegužės 18 d. ·

  Yahoo
  Satsuma Pharmaceuticals Announces FDA Acceptance of 505(b)(2) NDA for STS101, a Novel and Investigational Dihydroergotamine (DHE) Nasal Powder Product for the Acute Treatment of Migraine
• gegužės 18 d. ·

  Seeking Alpha
  Satsuma migraine therapy accepted for FDA review
• gegužės 18 d. ·

  Thefly.com
  Satsuma: FDA accepts NDA for STS101 for acute migraine treatment
• gegužės 15 d. ·

  TipRanks
  JonesTrading Sticks to Its Hold Rating for Satsuma Pharmaceuticals (STSA)
• balandžio 21 d. ·

  Yahoo
  Satsuma Pharmaceuticals Announces Three Abstracts Accepted at The 75th American Academy of Neurology Annual Meeting
• balandžio 21 d. ·

  Thefly.com
  Satsuma Pharmaceuticals announces three abstracts accepted at AAN meeting
• balandžio 19 d. ·

  Thefly.com
  Biotech Alert: Searches spiking for these stocks today
• balandžio 19 d. ·

  Fintel
  HC Wainwright & Co. Downgrades Satsuma Pharmaceuticals (STSA)